openPR Logo
Press release

Capecitabine Market 2023 - Size. Share, Segments, Data, Growth, And Forecast | Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG

09-28-2023 08:04 AM CET | Health & Medicine

Press release from: The Business research company

Capecitabine Market

Capecitabine Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Capecitabine Global Market Report 2023 identifies increasing incidence of cancer is expected to propel the growth of the capecitabine market. Capecitabine is used as a chemotherapeutic medication in cancer treatment, where it is enzymatically converted into the antimetabolite fluorouracil in the tumor, inhibiting DNA synthesis and slowing tumor tissue growth.

The global capecitabine market is expected to grow from $1.88 billion in 2022 to $2.06 billion in 2023 at a compound annual growth rate (CAGR) of 9.5%. The market size of global capecitabine is expected to reach $2.88 billion in 2027 at a CAGR of 8.8%.

Download Free Sample Of Capecitabine Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12240&type=smp

Major competitors in the capecitabine market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Sensus Healthcare Inc., Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Inc., Genentech Inc., Aurobindo Pharma Limited, Dr Reddy Laboratories Ltd., Sigma-Aldrich Corp, Cipla Inc., Hikma Pharmaceuticals plc, Lupin Limited, Alkem Laboratories Limited, Ranbaxy Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Accord Healthcare Ltd., Zentiva N.V., Reliance Life Sciences Pvt Ltd., Avita Medical Limited, Mylan Inc., and Sandoz Inc.

Developing novel therapies has emerged as a key trend gaining popularity in the capecitabine market. Major players operating in the capecitabine market are concentrating on creating advanced treatments in combination with capecitabine to strengthen their position in the market.

Read More On The Global Capecitabine Market Report Here:
https://www.thebusinessresearchcompany.com/report/capecitabine-global-market-report

The capecitabine market is segmented -
• By Drug Type: Branded, Generic
• By Drug Formulation: Tablet, Capsules
• By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
• By Application: Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer, Other Applications
• By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the capecitabine market.

The Business Research Company's "Global Capecitabine Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Capecitabine Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12240

The Table Of Content For The Capecitabine Market Include:
1. Capecitabine Market Executive Summary
2. Capecitabine Market Segments
3. Capecitabine Market Size And Capecitabine Market Growth Rate
4. Key Capecitabine Market Trends
5. Major Capecitabine Market Drivers
……
25. Key Mergers And Acquisitions In The Capecitabine Market
26. Top Capecitabine Companies
27. Capecitabine Market Opportunities And Strategies
28. Capecitabine Market, Conclusions And Recommendations
29. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Capecitabine Market 2023 - Size. Share, Segments, Data, Growth, And Forecast | Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG here

News-ID: 3228353 • Views:

More Releases from The Business research company

Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 Billion Milestone
Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ventricular Assist Device Market Size By 2025? The market size of the ventricular assist device has seen rapid expansion in recent years. A growth from $2.12 billion in 2024 to $2.37 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of 11.8%.
Key Trends Reshaping the Sunglasses Market: Leading Sunglass Brands Embrace AI With Chatgpt-Enabled Smart Eyewear Industry Transformation
Key Trends Reshaping the Sunglasses Market: Leading Sunglass Brands Embrace AI W …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sunglasses Market Size Growth Forecast: What to Expect by 2025? In recent times, the market size of sunglasses has been on a progressive rise. It is projected to increase from $18.11 billion in 2024 to an estimated $18.93 billion in 2025, experiencing a compound annual growth rate (CAGR) of
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Key Catalyst Accelerating PTA Balloon Catheter Market Growth in 2025
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Ke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. PTA Balloon Catheter Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the recent past, the market size for pta balloon catheter has seen substantial growth. The projections reveal that the growth scale will go up from $2.33 billion in 2024 to $2.56 billion in
Soaring Demand Set to Propel Nuclear Medicine Diagnostics Market to $12.38 Billion by 2029
Soaring Demand Set to Propel Nuclear Medicine Diagnostics Market to $12.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Nuclear Medicine Diagnostics Market Through 2025? In recent years, the nuclear medicine diagnostics market has seen a quick expansion. The market's size will increase from $7.16 billion in 2024 to $7.88 billion in 2025 at a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Capecitabine

Capecitabine Market Detailed Analysis and Forecast up to 2034
The Capecitabine Market Is Set To Grow At An Estimated CAGR Of 4.5% From 2025 To 2034, Rising From $1.2 Billion In 2024 To $1.8 Billion By 2034. On March 25, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Capecitabine market goods. The market study excludes key regions that are accelerating marketization. This section also gives
Revolutionizing Oncology: The Capecitabine Market's Next Frontier
"The Business Research Company recently released a comprehensive report on the Global Capecitabine Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of
Global Capecitabine Market Research Report 2023-2029
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is
Global Capecitabine Fumarate Market - Opportunities & Forecasts, 2020-2029
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global capecitabine fumarate market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future. Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able to identify the
Capecitabine Market Insights Deep Analysis 2019-2026
Capecitabine Market The global capecitabine market accounted for around USD 1,652 million in 2017 and is expected to grow at a healthy CAGR during the forecast period, 2019–2026. Capecitabine is a chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Cancer is the second leading cause of death worldwide–around 9.6 million deaths every year are caused by cancer, WHO. In addition, more than 70% of deaths occur in low
Capecitabine Market Excellent Growth 2020 Top Key Players-
Capecitabine Market Overview: The market research report on the Global Capecitabine Market offered by Straits Research, analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of the Global Capecitabine Market. The competition landscape, company overview, financials, recent developments and long-term investments related to the Global Capecitabine Market are mentioned in this report. Various parameters have been studied while estimating the market size. The revenue